Analyze Diet

Topic:Medication

The topic of medication in horses encompasses the study and application of pharmaceutical substances used to treat, manage, or prevent diseases and conditions in equine patients. This field involves understanding the pharmacokinetics and pharmacodynamics of various drugs, including their absorption, distribution, metabolism, and excretion in horses. Medications commonly administered to horses include non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, anthelmintics, and sedatives. The appropriate use of these medications is critical for ensuring therapeutic efficacy and minimizing adverse effects. Research in this area focuses on dosage optimization, drug interactions, resistance development, and withdrawal times to ensure both the health of the horse and compliance with regulatory standards. This page aggregates peer-reviewed studies and scholarly articles that explore the pharmacological aspects, clinical applications, and regulatory considerations of equine medications.
An FDA perspective on drug use in horses.
Journal of the American Veterinary Medical Association    May 1, 1990   Volume 196, Issue 9 1388-1389 
Beaulieu AJ, Meyers H.No abstract available
Clinical use of epidural xylazine in the horse.
Equine veterinary journal    May 1, 1990   Volume 22, Issue 3 180-181 doi: 10.1111/j.2042-3306.1990.tb04243.x
LeBlanc PH, Caron JP.Xylazine was administered into the epidural space of nine horses to facilitate various perineal manipulations (ie rectovaginal laceration repair, replacement of prolapsed rectum and urethral extension). The resulting caudal analgesia was sufficient for all procedures. The duration of analgesia from a single injection of epidural xylazine (0.17 to 0.22 mg/kg bodyweight) was at least 3.5 h. No horses were ataxic during or after the treatment. This trial demonstrates that xylazine given into the epidural space of horses provides prolonged regional analgesia which is sufficient for clinical use.
Propafenone kinetics in the horse. Comparative analysis of compartmental and noncompartmental models.
Journal of pharmacological methods    April 1, 1990   Volume 23, Issue 2 79-85 doi: 10.1016/0160-5402(90)90035-j
Puigdemont A, Riu JL, Guitart R, Arboix M.The propafenone kinetics after intravenous (i.v.) administration have been studied in the horse by a comparative analysis of compartmental and noncompartmental models. The pharmacokinetic parameters showed a large distribution (Vdss = 1021 +/- 211 L) and a high clearance (CI = 7019 +/- 1746 mL/min) of the drug. The plasma concentrations were very low, under 1 microgram/mL, in most cases; after 30 min these concentrations can be considered as nonefficient for the treatment of arrhythmia. There were no significant differences between pharmacokinetic parameters found with the use of compartmental...
[Locker room pharmacology].
Medizinische Monatsschrift fur Pharmazeuten    April 1, 1990   Volume 13, Issue 4 97 
Heinzl S.No abstract available
Sulfonamides and blood dyscrasias.
Journal of the American Veterinary Medical Association    March 1, 1990   Volume 196, Issue 5 681-682 
Dodds WJ.No abstract available
The influence of furosemide on plasma elimination and urinary excretion of drugs in standardbred horses.
Journal of veterinary pharmacology and therapeutics    March 1, 1990   Volume 13, Issue 1 93-104 doi: 10.1111/j.1365-2885.1990.tb00753.x
Stevenson AJ, Weber MP, Todi F, Mendonca M, Fenwick JD, Kwong E, Young L, Leavitt R, Nespolo R, Beaumier P.A study of the effects of intravenous administration of either 150 mg or 250 mg of furosemide to standardbred mares pre-treated with other drugs was undertaken to determine whether a unique pattern of drug elimination into urine and from plasma for each compound occurred. Furosemide significantly reduced the plasma concentrations of codeine compared to control 2-6 h after furosemide administration. In contrast, the plasma concentrations of theophylline, phenylbutazone, pentazocine, guaifenesin and flunixin were not markedly altered by furosemide. In the case of acepromazine, clenbuterol and fe...
Cimetidine for treatment of melanomas in three horses.
Journal of the American Veterinary Medical Association    February 1, 1990   Volume 196, Issue 3 449-452 
Goetz TE, Ogilvie GK, Keegan KG, Johnson PJ.Cimetidine, an H2 histamine antagonist, was used in the clinical management of progressive, multifocal melanomatosis in 3 adult gray horses. Prior to treatment, the tumors had increased rapidly in size and number in 2 horses (duration of 6 and 27 months, respectively) and slowly in the third horse (duration of 48 months). All 3 horses were treated with cimetidine (2.5 mg/kg of body weight, PO, q 8 h) for 2 months to 1 year. During treatment, the number and size of the melanomas decreased substantially (50 to 90%). The progression of the disease was halted in 2 horses and controlled in the thir...
Veterinary use of ivermectin.
Acta Leidensia    January 1, 1990   Volume 59, Issue 1-2 211-216 
Sutherland IH.Following the development of a unique claim structure encompassing both nematode and arthropod species, ivermectin was first introduced as a veterinary parasiticide in 1981. For cattle(c), sheep(s), horses(h) and pigs(p) injectable(c,s,p), oral(c,s,h) and topical(c) products are available delivering ivermectin at 200 to 500 micrograms/kg. Efficacy extends to nematodes of the gastrointestinal and respiratory tracts, conjunctival sac and soft tissues. Among the arthropod parasites claims have been established for the biting fly Haematobia irritans(c), the screw-worm Chrysomyia bezziana(c), larva...
[Anesthesia by injection of xylazine, ketamine and the benzodiazepine derivative climazolam and the use of the benzodiazepine antagonist Ro 15-3505].
Schweizer Archiv fur Tierheilkunde    January 1, 1990   Volume 132, Issue 5 251-257 
Kaegi B.25 horses which entered the clinic for minor surgery, received ketamine (2.2 mg/kg i.v.) for induction of anesthesia after previous sedation with xylazine (1.1 mg/kg i.v.). As soon as the horses were in the lateral recumbency, the benzodiazepine derivate climazolam was administered at a dose of 0.1 mg/kg i.v. (10 horses) or 0.2 mg/kg i.v. (15 horses). The anesthesia was maintained with repeated injections of ketamine (1.1 mg/kg i.v. every 9-12 minutes). At the end of the surgery, 20 minutes after the last ketamine injection, Ro 15-3505, a benzodiazepine antagonist, was injected at a dose of 0....
Efficacy of anthelmintics in horses.
The Veterinary record    December 2, 1989   Volume 125, Issue 23 584-585 
Manners H.No abstract available
Equine bandaging techniques.
The Veterinary clinics of North America. Equine practice    December 1, 1989   Volume 5, Issue 3 513-538 doi: 10.1016/s0749-0739(17)30572-2
Lindsay WA.Topical medications and bandages play an important role in the management of equine wounds. Certain water-soluble antibacterial ointments (povidone-iodine, polymixin-neosporin-bacitracin) may be appropriate for use on contaminated wounds. A well-designed equine bandage is usually composed of primary, secondary, and tertiary layers. Because so many different products are available, the practitioner is advised to become familiar with the handling characteristics of a few. Because of the irregular contours of the equine limb, only products that stretch and conform should be used. Bandages should ...
The use of long-acting neuroleptics, perphenazine enanthate and pipothiazine palmitate in two horses.
Journal of the South African Veterinary Association    December 1, 1989   Volume 60, Issue 4 208-209 
McCrindle CM, Ebedes H, Swan GE.Two Arabian horse stallions with behavioural problems were treated with long-acting neuroleptics in order to facilitate corrective training. Perphenazine enanthate, administered intramuscularly at a dose of 0.5 mg kg-1 had an effect for 30 d. Pipothiazine palmitate (1 mg kg-1) induced tranquilization of 30 d duration as well as extra-pyramidal clinical signs, ataxia and aphagia. Neither horse showed prolapse of the penis or haemolysis.
Pseudallescheria boydii keratomycosis in a horse.
Journal of the American Veterinary Medical Association    September 1, 1989   Volume 195, Issue 5 616-618 
Friedman DS, Schoster JV, Pickett JP, Dubielzig RR, Czuprynski C, Knoll JS, Wolfgram LJ.The fungal organism Pseudallescheria boydii was isolated from the cornea of a Quarter Horse with ulcerative keratitis. Despite aggressive hourly medication through a subpalpebral lavage system, with drugs including miconazole and natamycin, the cornea developed a stromal abscess. Orbital exenteration was performed after 3 weeks. The fungal isolate was later determined to be resistant to all 8 antifungal drugs tested. Microscopic examination of the cornea revealed fungal hyphae throughout the corneal stroma and penetrating the Descemet membrane. Pseudallescheria boydii has not been implicated p...
The pharmacokinetics of cefadroxil in the foal.
Journal of veterinary pharmacology and therapeutics    September 1, 1989   Volume 12, Issue 3 322-326 doi: 10.1111/j.1365-2885.1989.tb00678.x
D○ NE, Christensen JM, Craig AM.No abstract available
Adverse reaction to potentiated sulphonamides in horses?
The Veterinary record    August 5, 1989   Volume 125, Issue 6 138 doi: 10.1136/vr.125.6.138-a
Gray A.No abstract available
Federal equine drug control program.
The Canadian veterinary journal = La revue veterinaire canadienne    August 1, 1989   Volume 30, Issue 8 637-641 
Lalonde C.No abstract available
Effects of xylazine and/or butorphanol or neostigmine on myoelectric activity of the cecum and right ventral colon in female ponies.
American journal of veterinary research    July 1, 1989   Volume 50, Issue 7 1096-1101 
Rutkowski JA, Ross MW, Cullen K.Effects of xylazine HCl (0.5 mg/kg of body weight, IV) and/or butorphanol tartrate (0.04 mg/kg, IV) or neostigmine methylsulfate (0.022 mg/kg, IV) on myoelectric activity of the cecum and right ventral colon were studied in 4 conscious female ponies. Eight bipolar Ag/AgCl electrodes were sequentially placed on the seromuscular layer of the cecum (6 electrodes) and right ventral colon (2 electrodes). Recordings began 30 minutes before and continued for 90 minutes after drug administration. Each drug or drug combination was studied on 2 occasions in each pony. Two major patterns of coordinated s...
Disposition of triclabendazole in horses, ponies and donkeys.
Equine veterinary journal    July 1, 1989   Volume 21, Issue 4 305-307 doi: 10.1111/j.2042-3306.1989.tb02176.x
Kinabo LD, Bogan JA.No abstract available
Efficacy of ivermectin in oral drench and paste formulation against migrating larvae of experimentally inoculated Parascaris equorum.
American journal of veterinary research    July 1, 1989   Volume 50, Issue 7 1071-1073 
French DD, Klei TR, Taylor HW, Chapman MR.Twenty-one mixed-breed pony foals, reared and maintained under parasite-free conditions, were used to test the efficacy of ivermectin in oral drench and paste formulations (200 micrograms/kg) against 11-day-old migrating larvae of Parascaris equorum. Three replicates of 4 foals and 3 replicates of 3 foals were formed on the basis of age. Foals in replicates of 4 were randomly allocated to be indicators, or to receive vehicle (control) or ivermectin paste or ivermectin liquid. Foals in replicates of 3 were randomly allocated to receive vehicle or ivermectin paste or ivermectin liquid. The recov...
Effect of xylazine treatment on equine proximal gastrointestinal tract myoelectrical activity.
American journal of veterinary research    June 1, 1989   Volume 50, Issue 6 945-949 
Merritt AM, Campbell-Thompson ML, Lowrey S.Five 5 to 6 month old horses were surgically prepared with silver electrodes sutured to the serosa of gastric antrum, duodenum and proximal portions of the jejunum. Normal migrating motility complex (MMC) periodicity was determined during daytime hours in horses that were fed and horses from which food was withheld for 24 hours. Periodicity was defined as time span from the end of one period of regular spike activity (RSA) to the end of the next RSA in the MMC. The periodicity was 120.5 +/- 9.5 (SEM) minutes in horses from which food was withheld, and was 125.7 +/- 20.3 minutes in horses fed h...
Unusual reaction following overdose of xylazine in a mare.
The Veterinary record    May 13, 1989   Volume 124, Issue 19 511 doi: 10.1136/vr.124.19.511-a
Groenendyk J, Hall LW.No abstract available
The search for the ultimate equine sedative: are we ‘Waiting for Godot’? Combined use of detomidine with opiates in the horse.
Equine veterinary journal    March 1, 1989   Volume 21, Issue 2 96-97 
Jöchle W, Vähä-Vahe T.No abstract available
Bioavailability and pharmacokinetics of sulfamethazine in the pony.
Journal of veterinary pharmacology and therapeutics    March 1, 1989   Volume 12, Issue 1 99-102 doi: 10.1111/j.1365-2885.1989.tb00647.x
Wilson RC, Hammond LS, Clark CH, Ravis WR.No abstract available
[Blindness following digoxin therapy in a horse].
DTW. Deutsche tierarztliche Wochenschrift    February 1, 1989   Volume 96, Issue 2 75-76 
Staudacher G.No abstract available
A new insurance form.
The Veterinary record    January 21, 1989   Volume 124, Issue 3 71 doi: 10.1136/vr.124.3.71-a
Gerring EL, Digby NJ.No abstract available
[Individual glycoside therapy using serum concentration determination in heart insufficiency of horses].
Berliner und Munchener tierarztliche Wochenschrift    January 1, 1989   Volume 102, Issue 1 1-3 
Staudacher G.23 horses and one donkey with congestive heart failure are treated with a standardized methyldigoxin dose (0.0032 mg/kg of body weight). The therapy is controlled by the serum concentration of the cardiac glycoside. 4 horses have a higher and 13 horses a lower serum concentration as necessary for therapeutic approach. The influence of additional diseases and medications is demonstrated. Finally a rule for the evaluation of the individual therapeutic glycoside-dose is given.
The pony as an animal model for vascular implants.
Journal of investigative surgery : the official journal of the Academy of Surgical Research    January 1, 1989   Volume 2, Issue 1 75-84 doi: 10.3109/08941938909016504
Wagner-Mann CC, Hankes G, Purohit RC, Harrison I, Pablo L, Boudreaux MK, Boosinger TR, Conti J.This study evaluated the pony as a potentially suitable model for vascular implant research. Healthy, conditioned ponies were randomly assigned to one of three groups: group I, carotid artery autografts (n = 6); group II, e-PTFE carotid interpositional grafts (n = 5); and group III, e-PTFE carotid interpositional grafts plus aspirin (10 mg/kg) and dipyridamole (3.5 mg/kg) drug administration. It was found that autografts remained patent longest (mean = 396.2 days; grafts were still patent at time of writing) followed by group III grafts (157.5 days), with group II grafts remaining patent for t...
Interactions between chloramphenicol, acepromazine, phenylbutazone, rifampin and thiamylal in the horse.
Equine veterinary journal    January 1, 1989   Volume 21, Issue 1 34-38 doi: 10.1111/j.2042-3306.1989.tb02086.x
Burrows GE, MacAllister CG, Tripp P, Black J.The potential for interactions between chloramphenicol, phenylbutazone, acepromazine and thiamylal and chloramphenicol, rifampin, and phenylbutazone were evaluated in two groups of experiments. In the first, five horses were given thiamylal intravenously (iv) (6.6 mg/kg) after pretreatment with acepromazine, and the time of recumbency was determined. Administration of chloramphenicol iv (25 mg/kg) 1 h prior to anaesthesia significantly lengthened the recumbency time from 21.8 +/- 4.8 mins to 36.0 +/- 8.3 mins. There was an apparent but not statistically significant decrease in recumbency time ...
Clinical pharmacokinetics of metronidazole in horses.
Journal of veterinary pharmacology and therapeutics    December 1, 1988   Volume 11, Issue 4 417-420 doi: 10.1111/j.1365-2885.1988.tb00205.x
Baggot JD, Wilson WD, Hietala S.No abstract available
Actions of the novel gastrointestinal prokinetic agent cisapride on equine bowel motility.
Journal of veterinary pharmacology and therapeutics    December 1, 1988   Volume 11, Issue 4 314-321 doi: 10.1111/j.1365-2885.1988.tb00190.x
King JN, Gerring EL.The effect of cisapride was evaluated on the normal fasting bowel motility of four ponies with chronically implanted electromechanical transducers. Cisapride was infused over 60-min periods at 0.05 mg/kg (n = 4), 0.1 mg/kg (n = 5) and 0.25 mg/kg (n = 5). It produced marked and prolonged increases in electrical and mechanical activity at all sites examined. In the stomach there was increased total contraction activity with increased contraction amplitude and a slight reduction in rate. In the small intestine there was an increase in irregular (phase II) activity with an increase in number and a...
1 21 22 23 24 25 40